Literature DB >> 6259865

Effects of two histamine H2-receptor blocking drugs on basal levels of gonadotrophins, prolactin, testosterone and oestradiol-17 beta during treatment of duodenal ulcer in male patients.

N R Peden, E J Boyd, M C Browning, J H Saunders, K G Wormsley.   

Abstract

In a study of 51 male patients with duodenal ulcer, treatment with cimetidine was accompanied by an increase in basal levels of serum testosterone. Treatment with ranitidine, a new histamine H2-receptor antagonist, produced no such effect. It is concluded that cimetidine had antiandrogenic activity in man which is separate from the histamine H2-receptor blocking activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6259865     DOI: 10.1530/acta.0.0960564

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  21 in total

Review 1.  Nizatidine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A H Price; R N Brogden
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 2.  Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  H D Langtry; S M Grant; K L Goa
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

3.  Plasma concentrations of pituitary and peripheral hormones during ranitidine treatment for two years in men with duodenal ulcer.

Authors:  U Knigge; B Thuesen; A Dejgaard; P Bennett; P M Christiansen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Antiprostatic effect of cimetidine in rats.

Authors:  P Pinelli; S Trivulzio; R Colombo; D Cocchi; R Faravelli; F Caviezel; G Galmozzi; R Cavallaro
Journal:  Agents Actions       Date:  1987-12

5.  Ranitidine and testosterone secretion in man.

Authors:  V Savarino; M Giusti; C Mansi; M Marugo; G Delitala; G Celle
Journal:  Br J Clin Pharmacol       Date:  1983-05       Impact factor: 4.335

Review 6.  Safety of acid-suppressing drugs.

Authors:  R A Smallwood; R G Berlin; N Castagnoli; H P Festen; C J Hawkey; S K Lam; M J Langman; P Lundborg; A Parkinson
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

Review 7.  Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-10       Impact factor: 9.546

Review 8.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

Review 9.  Behavioural effects of histamine and its antagonists: a review.

Authors:  J M White; G R Rumbold
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

10.  Enhanced ERbeta immunoexpression and apoptosis in the germ cells of cimetidine-treated rats.

Authors:  Estela Sasso-Cerri
Journal:  Reprod Biol Endocrinol       Date:  2009-11-18       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.